Cantor Fitzgerald keeps an Overweight rating and $925 price target on Eli Lilly (LLY). The White House / FDA joint media conference this afternoon ...
Source LinkCantor Fitzgerald keeps an Overweight rating and $925 price target on Eli Lilly (LLY). The White House / FDA joint media conference this afternoon ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.